Epstein Files Search

EFTA01088033Set 9

2016-04-1921p9,988w

Today, US Biotech/Health Care is only AMGN Amgen Inc. 118,509 1.64 34.6% CELG Celgene Corporation 84,174 1.57 35.8% one-third active, two-thirds passive—the opposite ... BMRN's pipeline. Minket Amenca 4,* Biotechnology 19 April 2016 9 Merrill Lynch EFTA01088041 Celgene (CELG) I Buy I B-1-9 I $125 CELG's clinical specialty is multiple ... delays in pipeline development, 4) unexpected safety findings, and 5) greater than expected competition. Celgene Corp. (CELG) Our 5125 price objective for CELG is based on a 22x multiple

https://www.justice.gov/epstein/files/DataSet%209/EFTA01088033.pdf

EFTA01199422Set 9

14p8,572w

144A offering) of securities of Akebia Therapeutics Inc. AMAG Pharmaceuticals, Inc., gen Inc., Celgene Corp. Chimerix Inc. Cubist Pharmaceuticals Inc., Gilead Sciences Inc.. GW Pharmaceuticals PLC. Ironwood Pharmaceuticals ... from Akebia Therapeutics Inc, AMAG Pharmaceuticals. Inc.. Amgen Inc.. Biogen Idec Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences Inc.. GW Pharmaceuticals PLC. Ironwood Pharmaceuticals ... Alexion Pharmaceuticals. Alnylam Pharmaceuticals, AMAG Pharmaceuticals. Inc., Amgen.Inc., Auxilium Pharmaceuticals, Biogen Idec Inc. Celgene Corp, Chimerix Inc. Cubist Pharmaceuticals Inc.. Gilead Sciences Inc.. GW Pharmaceuticals PLC. ImmunoGen

https://www.justice.gov/epstein/files/DataSet%209/EFTA01199422.pdf

EFTA00598622Set 9

14p8,563w

144A offering) of securities of Akebia Therapeutics Inc. AMAG Pharmaceuticals, Inc., Amgen Inc., Celgene Corp. Chimenx Inc. Cubist Pharmaceuticals Inc., Gilead Sciences Inc.. GW Pharmaceuticals PLC. Ironwood Pharmaceuticals ... from Akebia Therapeutics Inc, AMAG Pharmaceuticals. Inc.. Amgen Inc.. Biogen Idec Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences Inc.. GW Pharmaceuticals PLC. Ironwood Pharmaceuticals ... Alexion Pharmaceuticals. Alnylam Pharmaceuticals, AMAG Pharmaceuticals. Inc., Amgen.Inc., Auxilium Pharmaceuticals, Biogen Idec Inc. Celgene Corp, Chimerix Inc. Cubist Pharmaceuticals Inc.. Gilead Sciences Inc.. GW Pharmaceuticals PLC. ImmunoGen

https://www.justice.gov/epstein/files/DataSet%209/EFTA00598622.pdf

EFTA01260699Set 9

108p21,101w

Statements SDNYGM,351769 CONFIDENTIAL EFTA_0032J461 EFTA01260699 0.DRED EMAOUOM ITS WHOLLY CIAKO SLASI.IANY orricz SERVICIVG

https://www.justice.gov/epstein/files/DataSet%209/EFTA01260699.pdf

EFTA00598607Set 9

2014-07-2313p8,093w

offering (or 144A offering) of securities of Akebia TherapeuticsInc. AMAG Pharmaceuticals, Inc., Amgen Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences Inc., GW Pharmaceuticals PLC. Ironwood Pharmaceuticals ... Akebia Therapeutics Inc, AMAG Pharmaceuticals. Inc.. Amgen Inc.. Biogen Mac Inc.. Celgene Corp, Chimerix Inc Cubist Pharmaceuticals Inc.. Gilead Sciences Inc.. GW Pharmaceuticals PLC, Ironwood ... than investment banking services from Amgen Inc.. Auxilium Pharmaceuticals. Biogen idec Inc.. Celgene Corp, Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals. Within the last 12 months. Morgan Stanley has provided

https://www.justice.gov/epstein/files/DataSet%209/EFTA00598607.pdf

EFTA01199408Set 9

2014-07-2313p8,089w

offering (or 144A offering) of securities of Akebia TherapeuticsInc. AMAG Pharmaceuticals, Inc., Amgen Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences Inc., GW Pharmaceuticals PLC. Ironwood Pharmaceuticals ... Akebia Therapeutics Inc, AMAG Pharmaceuticals. Inc.. Amgen Inc.. Biogen Mac Inc.. Celgene Corp, Chimerix Inc Cubist Pharmaceuticals Inc.. Gilead Sciences Inc.. GW Pharmaceuticals PLC, Ironwood ... than investment banking services from Amgen Inc.. Auxilium Pharmaceuticals. Biogen idec Inc.. Celgene Corp, Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals. Within the last 12 months. Morgan Stanley has provided

https://www.justice.gov/epstein/files/DataSet%209/EFTA01199408.pdf

EFTA01592748Set 10

2005-09-0129p3,227w

2F8EE0 S/D FINANCING FROM 2F8EE0 TO 746FY0 FUNDS RECEIVED BY WIRE -625,000 CELGENE CORP NOTE EFTA01592763 01.7500 06/01/2008 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 ... JOURNAL 03 09/15 SOLD 03 09/15 SOLD 01 09/15 BOUGHT QUANTITY DESCRIPTION 1,000 CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 24,500 CELGENE CORPORATION OFFSHORE ARRANGING FLIP ... 736FY0 FROM 746FY0 -24,500 CELGENE CORPORATION DONE AT DEUTSCHE BNK/ALEX BROWN -1,000 CELGENE CORPORATION 625,000 CELGENE CORP NOTE DONE AT EDGETRADE.COM INC. 01.7500 06/01/2008 CORRECTION DONE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01592748.pdf

EFTA01593408Set 10

2005-09-0149p4,944w

MARK TO MARKET MARK TO MARKET MARK TO MARKET MARK TO MARKET 625,000 CELGENE CORP NOTE 01.7500 06/01/2008 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 MARK TO MARKET ... CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 -24,500 CELGENE CORPORATION EFTA01593433 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 FROM 736FY0 TO 746FY0 736FY0 TO 746FY0 USD/EUR MARK ... STAR - Hold PROVIDER:Standard & Poor's 426 (S) CV THERAPEUTICS INC 25,500 (S) CELGENE CORPORATION 157,200 (S) CENTERPOINT ENERGY INC *CSFB RATING :NEUTRAL INDEPENDENT RATING:3 STAR - Hold

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593408.pdf

EFTA01581893Set 10

2005-09-011p284w

MONTH TYPE DATE TRANSACTION QUANTITY DESCRIPTION PRICE DEBIT CREDIT 03 09/15 JOURNAL 1, 000 CELGENE CORPORATION 54, 00 0.4 9 OFFSHORE ARRANGING FLIP TO FROM 03 09/15 JOURNAL ... CELGENE CORPORATION 1,321,719.74 OFFSHORE ARRANGING FLI P TO 736F10 FROM 03 09/15 SOLD -24, 500 CELGENE CORPORATION 53 .9 500 0 1, 321, 719 .74 DONE AT DEUTSCHE ... BROWN 03 09/15 SOLD -1, 000 CELGENE CORPORATION 54 .0 075 0 54,000.49 DONE AT EDGE TRADE -COM INC. 01 09/15 BOUGHT 625, 000 CELGENE CORP NOTE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01581893.pdf

EFTA00196824Set 9

108p21,527w

Statements EFTA00196824 CLEARED THROUGH ITS WHOLLY 01W.IED SUBSIDIARY OFFICE SERVICING YOUR ACCOUNT Eleel.508016 SOOWEN, CND

https://www.justice.gov/epstein/files/DataSet%209/EFTA00196824.pdf

EFTA01593041Set 10

2007-03-0123p2,423w

05/15/23 03.7500 05/15/2023 TO 736FY0 FROM 746FY0 MARK TO MARKET 150 CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 -51,600 CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM ... CELG 1.75 06/01/08 01.7500 06/01/2008 CORRECTION DONE AT MORGAN, STANLEY AND COMPANY, INCORPORATED -150 CELGENE CORPORATION DONE AT EDGETRADE.COM INC. 184,199 CENTERPOINT ENERGY INC DONE AT MORGAN, STANLEY ... COMPANY, INCORPORATED 51,600 CELGENE CORPORATION DONE AT MORGAN, STANLEY AND COMPANY, INCORPORATED 1,900 CBRL GROUP INC DONE AT EDGETRADE.COM INC. FROM 736FY0 TO 746FY0 FROM 736FY0 TO 746FY0

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593041.pdf

EFTA00018860Set 8

2019-08-276p2,487w

ACQUISITIONS American International Group Inc. Amgen Inc. 5 Firms Shape Amgen's $13.4B Celgene Drug Buy Apollo Commercial Real Estate Amgen will shell out $13.4 billion in cash ... snap up Celgene's psoriasis and Apple Inc. psoriatic arthritis drug, a deal shaped by five law firms that is aimed at lessening competition concerns with Bristol-Myers Squibb ... Celgene BB&T Corp. takeover. BlackBerry Ltd. Read full article » Bristol-Myers Squibb Co. Brookfield Properties Corp. BANKRUPTCY CBRE Group Inc. Celgene Corp. US Trustee Skeptical As Aegerion Creditors

https://www.justice.gov/epstein/files/DataSet%208/EFTA00018860.pdf

EFTA00791759Set 9

2016-12-0134p13,741w

CUSIP: 110122108 10/07/16 ' 5D0.000 55.4700 27,734.85 58.4400 29,220.00 1,485.15 780.00 2.66% CELGENE CORP Security Identifier: CELG Dividend Option: Cash CUSIP: 151020104 04/09/12

https://www.justice.gov/epstein/files/DataSet%209/EFTA00791759.pdf

EFTA00642436Set 9

2013-04-2121p13,686w

drug samples soon after it was passed. In 2009, generic companies began complaining that Celgene had refused to sell them samples of Thalomid, the drug better known as thalidomide that ... treat cancer and leprosy, and a related drug, Revlimid. Lannett, a generic company, sued Celgene, claiming its practices were anti- competitive, and the case was settled. The trade commission ... Connecticut attorney general started investigations, which Celgene has said are still under way. At least one company, Gilead Sciences, explicitly restricts access to samples. Pharmacies and other institutions that

https://www.justice.gov/epstein/files/DataSet%209/EFTA00642436.pdf

EFTA01593975Set 10

2006-11-0131p3,452w

MARKET FUNDS PAID BY WIRE WIRE TO CITIBANK FUT MGN MARK TO MARKET -450 CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 -1,400 CENTERPOINT ENERGY INC OFFSHORE ARRANGING ... OUTPERFORM INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's 51,450 (S) CELGENE CORPORATION 183,249 (S) CENTERPOINT ENERGY INC :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor ... 04/03/2032 CMS ENERGY CORP SR NT-B CV 23 CSX CORP BOND CVT CELGENE CORP CVT EDO CORP CVT SR SUB NTS HCC INS HLDGS INC NT CVT MASCO CORP

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593975.pdf

EFTA01593806Set 10

2006-08-0135p3,769w

RATING :OUTPERFORM INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's 51,000 (S) CELGENE CORPORATION 154,147 (S) CENTERPOINT ENERGY INC *CSSU RATING :UNDERPERFORM INDEPENDENT RATING:3 STAR - Hold ... ZERO 32 CMS ENERGY CORP SR NT-B CV 23 CSX CORP BOND CVT CELGENE CORP CVT CHENIERE ENERGY INC CVT 144A EDO CORP CVT SR SUB NTS GENERAL MTRS

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593806.pdf

EFTA01593841Set 10

2006-12-0128p3,134w

INCORPORATED :OUTPERFORM INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's 51,450 (S) CELGENE CORPORATION 175,499 (S) CENTERPOINT ENERGY INC :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard ... 04/03/2032 CMS ENERGY CORP SR NT-B CV 23 CSX CORP BOND CVT CELGENE CORP CVT EDO CORP CVT SR SUB NTS HCC INS HLDGS INC NT CVT MASCO CORP

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593841.pdf

EFTA01593782Set 10

2007-03-0124p2,665w

05/15/23 03.7500 05/15/2023 TO 736FY0 FROM 746FY0 MARK TO MARKET -150 CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 51,600 CELGENE CORPORATION OFFSHORE ARRANGING FLIP TO 736FY0 FROM

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593782.pdf

EFTA01593563Set 10

2005-11-0154p5,367w

STAR - Hold PROVIDER:Standard & Poor's 426 (S) CV THERAPEUTICS INC 25,500 (S) CELGENE CORPORATION 149,200 (S) CENTERPOINT ENERGY INC *CSFB RATING 10,000 :NEUTRAL INDEPENDENT RATING ... ZERO 32 CMS ENERGY CORP SR NT-B CV 23 CSX CORP BOND CVT CELGENE CORP CVT 03.3750 07/15/2023 10/30/2021 CV THERAPEUTICS INC CVT 03.2500 08/16/2013 01.7500 06/01/2008 CENTERPOINT ENERGY

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593563.pdf

EFTA01582416Set 10

2007-03-011p228w

FROM 03 03/02 MRKD/MARKET MARK TO MARKET 71,607.26 03 03/02 JOURNAL -150 CELGENE CORPORATION 8,073.54 OFF H RE ARRANGING FLIP TO FROM 03 03/02 JOURNAL 51,600 CELGENE

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01582416.pdf